Prehospital Fibrinolytic Therapy Followed by Urgent Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction

• American Heart Association: Heart Disease and Stroke Statistics – 2006 Update. 2–43 (2006).
   Google Scholar
• Boersma E , MaasAC, DeckersJW, SimoonsML: Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour.Lancet, 348, 771–775 (1996).
   PubMed Web of Science ®Google Scholar
• Cannon CP , GibsonCM, LambrewCTet al.: Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.JAMA, 283, 2941–2947 (2000).
   PubMed Web of Science ®Google Scholar
• Antman EM , AnbeDT, ArmstrongPWet al.: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary.Circulation, 110, 588–636 (2004).
   PubMed Web of Science ®Google Scholar
• Bonnefoy E , LapostolleF, LeizoroviczAet al.: Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study.Lancet, 360, 825–829 (2002).
   PubMed Web of Science ®Google Scholar
• Steg PG , BonnefoyE, ChabaudSet al.: Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty.Circulation, 108, 2851–2856 (2003).
   PubMed Web of Science ®Google Scholar
• Danchin N , BlanchardD, StegPGet al.: Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome.Circulation, 110, 1909–1915 (2004).
   PubMed Web of Science ®Google Scholar
• Thiele H , EngelmannL, ElsnerKet al.: Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction.Eur. Heart J., 26, 1956–1963 (2005).
   PubMed Web of Science ®Google Scholar
• Eagle KA , GoodmanSG, AvezumAet al.: Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events.Lancet, 359, 373–377 (2002).
   PubMed Web of Science ®Google Scholar
• Keeley EC , BouraJA, GrinesCL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.Lancet, 361, 13–20 (2003).
   PubMed Web of Science ®Google Scholar
• The GUSTO Angiographic Investigators: The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N. Engl. J. Med., 329, 1615–1622 (1993).
   PubMed Web of Science ®Google Scholar
• Herrmann HC : Triple therapy for acute myocardial infarction: combining fibrinolysis, platelet IIb/IIIa inhibition, and percutaneous coronary intervention.Am. J. Cardiol., 85, 10–16 (2000).
   Web of Science ®Google Scholar
• Patel TN , BavryAA, KumbhaniDJ, EllisSG: A meta-analysis of randomized trials of rescue percutaneous coronary intervention after failed fibrinolysis.Am. J. Cardiol., 97, 1685–1690 (2006).
   PubMedGoogle Scholar
• Collet JP , MontalescotGet al., Le May M : Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy. J. Am. Coll. Cardiol., 48, 1326–1333 (2006).
   PubMed Web of Science ®Google Scholar
• Wijeysundera HC , VijayaraghavanR, NallamothuBKet al.: Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials.J. Am. Coll. Cardiol., 49, 422–430 (2007).
   PubMed Web of Science ®Google Scholar
• Kunadian B , SuttonAG, VijayalakshmiKet al.: Early invasive versus conservative treatment in patients with failed fibrinolysis – no late survival benefit: the final analysis of the Middlesbrough Early Revascularisation to Limit Infarction (MERLIN) randomized trial.Am. Heart J., 153(5), 763–771.
   PubMed Web of Science ®Google Scholar
• Sutton AG , CampbellPG, GrahamRet al.: A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial.J. Am. Coll. Cardiol., 44, 287–296 (2004).
   PubMed Web of Science ®Google Scholar
• Kunadian B , VijayalakshmiK, DunningJet al.: Towards an understanding of the role of rescue angioplasty for failed fibrinolysis: comparison of the MERLIN, RESCUE and REACT trials.J. Invasive Cardiol., 19, 359–368 (2007).
   PubMedGoogle Scholar
• Andersen HR , NielsenTT, RasmussenKet al.: A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.N. Engl. J. Med., 349, 733–742 (2003).
   PubMed Web of Science ®Google Scholar
• Widimský P , BudesinskýT, VorácDet al.: Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomized national multicentre trial –PRAGUE-2.Eur. Heart J., 24, 94–104 (2003).
   PubMed Web of Science ®Google Scholar
• The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators: A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N. Engl. J. Med., 336, 1621–1628 (1997).
   PubMed Web of Science ®Google Scholar
• Stone GW , GrinesCL, O‘NeillWW: Primary coronary angioplasty versus thrombolysis.N. Engl. J. Med., 337, 1168–1169 (1997).
   PubMedGoogle Scholar
• Christian TF , O‘KeefeJH, DeWoodMAet al.: Intercenter variability in outcome for patients treated with direct coronary angioplasty during acute myocardial infarction.Am. Heart J., 135, 310–317 (1998).
   PubMed Web of Science ®Google Scholar
• Liem AL , van t Hof AW, Hoorntje JC, de Boer MJ, Suryapranata H, Zijlstra F: Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty. J. Am. Coll. Cardiol., 32, 629–633 (1998).
   PubMed Web of Science ®Google Scholar
• De Luca G , SuryapranataH, OttervangerJP, AntmanEM: Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts.Circulation, 109, 1223–1225 (2004).
   PubMed Web of Science ®Google Scholar
• Schömig A , NdrepepaG, MehilliJet al.: Therapy-dependent influence of time to- treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis.Circulation, 108, 1084–1088 (2003).
   PubMedGoogle Scholar
• Antoniucci D , ValentiR, MiglioriniAet al.: Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty.Am. J. Cardiol., 89, 1248–1252 (2002).
   PubMedGoogle Scholar
• Simes RJ , TopolEJ, HolmesDRet al. Jr : Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: importance of early and complete infarct artery reperfusion. Circulation, 91, 1923–1928 (1995).
   PubMed Web of Science ®Google Scholar
• Ross AM , CoyneKS, MoreyraEet al.: Extended mortality benefit of early postinfarction reperfusion: Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial.Circulation, 97, 1549–1556 (1998).
   PubMed Web of Science ®Google Scholar
• Gibson CM , PrideYB, FrederickPD: Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006.Am. Heart J., 156(6), 1035–1044 (2008).
   PubMed Web of Science ®Google Scholar
• Berger AK , RadfordMJ, KrumholzHM: Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: analysis of the Cooperative Cardiovascular Project.Am. Heart J., 139, 985–992 (2000).
   PubMed Web of Science ®Google Scholar
• Cannon CP , GibsonCM, LambrewCet al.: Longer thrombolysis door-to-needle times are associated with increased mortality in acute myocardial infarction: an analysis of 85,589 patients in the National Registry of Myocardial Infarction.J. Am. Coll. Cardiol., 35, 376A (2000).
   Google Scholar
• Berger PB , EllisSG, HolmesDRet al. Jr : Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation, 100, 14–20 (1999).
   PubMed Web of Science ®Google Scholar
• DeLuca G , SuryapranataH, OttervangerJPet al.: Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts.Circulation, 109, 1223–1225 (2004).
   PubMedGoogle Scholar
• McNamara RL , HerrinJ, BradleyEHet al.: Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002.J. Am. Coll. Cardiol., 47, 45–51 (2006).
   PubMed Web of Science ®Google Scholar
• Le May MR , WellsGA, LabinazMet al.: Combined Angioplasty and Pharmacological Intervention Versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI Study).J. Am. Coll. Cardiol., 46, 417–424 (2005).
   PubMed Web of Science ®Google Scholar
• Bonnefoy E , LapostolleF, LeizoroviczAet al., for the CAPTIM study group: Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomized study. Lancet, 360, 825–829 (2002).
   PubMed Web of Science ®Google Scholar
• Steg PG , BonnefoyE, ChabaudSet al.; for the Comparison of Angioplasty Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) Investigators: Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty. Circulation, 108, 2851–2856 (2003).
   PubMed Web of Science ®Google Scholar
• Boersma E : The PCAT-2 Trialists‘ Collaborative Group Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction.Eur. Heart J., 27, 779–788 (2006).
   PubMed Web of Science ®Google Scholar
• Danchin N , DurandE, BlanchardDet al.: Pre-hospital thrombolysis in perspective.Eur. Heart J., 29, 2835–2842 (2008).
   PubMed Web of Science ®Google Scholar
• Kalla K , ChristG, KarnikRet al.; for the Vienna STEMI Registry Group: Implementation of guidelines improves the standard of care. The Viennese Registry on Reperfusion Strategies in ST-Elevation Myocardial Infarction (Vienna STEMI Registry). Circulation, 113, 2398–2405 (2006).
   PubMed Web of Science ®Google Scholar
• Stenestrand U , LindbäckJ, WallentinL, for the RIKS-HIA Registry: Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA, 296, 1749–1756 (2006).
   PubMed Web of Science ®Google Scholar
• Smalling RW , GieslerGM, JulapalliVRet al.: Pre-hospital reduced-dose fibrinolysis coupled with urgent percutaneous coronary intervention reduces time to reperfusion and improves angiographic perfusion score compared with prehospital fibrinolysis alone or primary percutaneous coronary intervention: results of the PATCAR Pilot Trial.J. Am. Coll. Cardiol. Oct 16 50, 1612–1614 (2007).
   PubMed Web of Science ®Google Scholar
• Ellis SG , TenderaMet al., de Belder MA : Facilitated PCI in Patients with ST-Elevation Myocardial Infarction N. Engl. J. Med., 358, 2205–2217 (2008).
   PubMed Web of Science ®Google Scholar
• Keeley EC , BouraJA, GrinesCL: Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials.Lancet, 367, 579–588 (2006).
   PubMed Web of Science ®Google Scholar
• ASSENT-4 PCI investigators. Primary versus tenecteplase facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet, 367, 569–578 (2006).
   PubMed Web of Science ®Google Scholar
• Van de Werf F , ArmstrongPW, GrangerC, WallentinL: Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.Lancet, 358, 605–613 (2001).
   PubMed Web of Science ®Google Scholar
• Desmet W , RossA, GrangerCet al.: Tenecteplase-pretrearted STEMI patients with TIMI 0–2 flow before PCI are less likely to have TIMI 3 flow after PCI.J. Am. Coll. Cardiol., 49, 227A–227A (2007).
   PubMed Web of Science ®Google Scholar
• Widimsky P , GrochL, ZelizkoMet al.: Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study.Eur. Heart J., 21, 823–831 (2000).
   PubMed Web of Science ®Google Scholar
• Fernández-Avilés F , AlonsoJJ, PeñaGet al.: Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial.Eur. Heart J., 28(8), 949–960.
   PubMed Web of Science ®Google Scholar
• Ross AM , CoyneKS, ReinerJSet al.: A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial.J. Am. Coll. Cardiol., 34, 1954–1962 (1999).
   PubMed Web of Science ®Google Scholar
• O‘Neill WW , WeintraubR, GrinesCLet al.: A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction.Circulation, 86, 1710–1717 (1992).
   PubMed Web of Science ®Google Scholar
• Kanakakis J , NanasJN, TsagalouEPet al.: Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: The Athens PCI trial.Catheter. Cardiovasc. Interv. 2009 Jan 27. [Epub ahead of print]
   Web of Science ®Google Scholar
• McKay RG , DadaMR, MatherJFet al.: Comparison of outcomes and safety of ‘facilitated‘ versus primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.Am. J. Cardiol., 103(3), 316–321
   PubMed Web of Science ®Google Scholar
• Denktas A , AtharH, HenryTet al.: Reduced-dose fibrinolytic acceleration of stemi treatment coupled with urgent percutaneous intervention compared with primary PCI alone: results of the AMICO Registry AMICO: Alliance for myocardial infarction care optimizationJ. Am. Coll. Cardiol. Intv., 1, 504–510 (2008).
   Google Scholar
• Cantor WJ , FithcettD, BorgundvaagBet al.: Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction.Am. Heart J., 155, 19–25 (2008).
   PubMed Web of Science ®Google Scholar
• Di Mario C , DudekD, PiscioneFet al.: Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial.Lancet., 371(9612), 559–568 (2008).
   PubMed Web of Science ®Google Scholar
• Dudek D , DziewierzA, SiudakZet al.: Transportation with very long transfer delays (>90 min) for facilitated PCI with reduced-dose fibrinolysis in patients with ST-segment elevation myocardial infarction The Krakow Network.Int. J. Cardiol. (2008) (Epub ahead of print).
   Web of Science ®Google Scholar
• Manari A , GuiducciV, MuiàNet al.: Angioplasty in acute myocardial infarction after low-dose alteplase and abciximab in transferred patients. A comparison with primary angioplasty on site.Ital. Heart J., 4(5), 11–317 (2003).
   Google Scholar
• Antman EM , HandM, ArmstrongPWet al.: 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Behalf of the 2004 Writing Committee, Elliott M. Antman, Mary Hand, Paul W. Management of Patients With ST-Elevation Myocardial Infarction, Writing on Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Society, Endorsed by the American Academy of Family Physicians, 2007 Writing Practice Guidelines, Developed in Collaboration With the Canadian Cardiovascular American College of Cardiology/American Heart Association Task Force on Patients With ST-Elevation Myocardial Infarction.J. Am. Coll. Cardiol., 51, 210–247 (2008).
   PubMed Web of Science ®Google Scholar
• Nallamothu BK , BatesER, HerrinJet al.: Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis.Circulation, 111, 761–767 (2005).
   PubMed Web of Science ®Google Scholar
• Sinno MC , KhanalS, Al-MallahMHet al.: The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.Am. Heart J., 153, 579–586 (2007).
   PubMed Web of Science ®Google Scholar
• ESC Committee for Practice Guidelines: Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur. Heart J., 29, 2909–2945 (2008).
   PubMed Web of Science ®Google Scholar
• Bouten MJ , SimoonsML, HartmanJAet al.: Prehospital thrombolysis with alteplase (rt-PA) in acute myocardial infarction.Eur. Heart J., 13, 925–931 (1992).
   PubMedGoogle Scholar
• Grijseels EW , DeckersJW, HoesAWet al.: Pre-hospital triage of patients with suspected myocardial infarction. Evaluation of previously developed algorithms and new proposals.Eur. Heart J., 16, 325–332 (1995).
   PubMedGoogle Scholar

Website

• Boehringer Ingelheim - Prehospital thrombolysis for AMI to be studied in new clinical trial (2007). www.boehringeringelheim.com/corporate/news/press_releases/detail.asp?ID=4874
   Google Scholar